Provided by Tiger Fintech (Singapore) Pte. Ltd.

Diffusion Pharmaceuticals Inc

4.40
+0.0000
Volume:- -
Turnover:1.67M
Market Cap:5.98M
PE:-0.46
High:4.40
Open:4.40
Low:4.40
Close:4.40
Loading ...

Company Profile

Company Name:
Diffusion Pharmaceuticals Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.